Barclays’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$546M Sell
1,130,944
-423,236
-27% -$112M 0.1% 125
2026
Q1
$170M Buy
1,554,180
+404,100
+35% +$57.6M 0.04% 343
2025
Q4
$191M Sell
1,150,080
-864,776
-43% -$145M 0.05% 293
2025
Q3
$395M Buy
2,014,856
+1,961,995
+3,712% +$323M 0.09% 165
2025
Q2
$4.78M Buy
52,861
+46,919
+790% +$3.71M ﹤0.01% 2175
2025
Q1
$355K Sell
5,942
-86,520
-94% -$8M ﹤0.01% 3730
2024
Q4
$12.2M Buy
92,462
+2,551
+3% +$239K ﹤0.01% 1430
2024
Q3
$4.71M Buy
89,911
+89,123
+11,310% +$4.18M ﹤0.01% 2151
2024
Q2
$47.7K Sell
788
-4,112
-84% -$285K ﹤0.01% 4229
2024
Q1
$364K Buy
+4,900
New +$363K ﹤0.01% 3781

Other funds holding ALAB

Barclays's ALAB Position: Q2 2026 in Review

Barclays reduced its Astera Labs (ALAB) stake by 27% in Q2 2026, selling an estimated $112M and leaving 1,130,944 shares worth $546M. The position accounts for 0.1% of the portfolio, ranked #125.

Barclays first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Barclays held 1,130,944 shares of Astera Labs worth $546M as of Q2 2026.
  • Barclays sold 423,236 Astera Labs shares in Q2 2026, an estimated $112M.
  • Astera Labs made up 0.1% of Barclays's portfolio in Q2 2026, its #125 holding.
  • Barclays first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.